LK
Lalan Kumar Singh
About Lalan Kumar Singh
Data last updated:
Lalan Kumar Singh is a Director at Sorbax Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Sorbax Pharmaceuticals Private Limited reported revenue of ₹6.71 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sorbax Pharmaceuticals Private Limited U24290HP2020PTC008140 | Director | 15 Oct 2020 | 2020 | ₹6.71 Cr (FY 2025) | Active |
Board colleagues of Lalan Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dheeraj Gangadhara Shetty | 09090341 | Sorbax Pharmaceuticals Private Limited | Director |
| Kota Suresh Prabhu | 08920717 | Sorbax Pharmaceuticals Private Limited | Director |
| Manjeet Kaur | 10603049 | Sorbax Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lalan Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lalan Kumar Singh
Lalan Kumar Singh currently holds 1 directorship: Sorbax Pharmaceuticals Private Limited (Director, since 15 Oct 2020, revenue ₹6.71 Cr (FY 2025)).
Lalan Kumar Singh was first appointed on 15 Oct 2020 as Director at Sorbax Pharmaceuticals Private Limited.
The current boards of Lalan Kumar Singh's companies include Dheeraj Gangadhara Shetty (Sorbax Pharmaceuticals Private Limited), Kota Suresh Prabhu (Sorbax Pharmaceuticals Private Limited), Manjeet Kaur (Sorbax Pharmaceuticals Private Limited).